Relationships between Anti-Ganglioside Antibodies and Clinical Characteristics of Guillain-Barré Syndrome

Internal Medicine

Volumn 36, Issue 9, 1997, Pages 607-612

  Irie, Sachiko ^a,c   Saito, Toyokazu ^a   Kanazawa, Naomi ^b   Nukazawa, Tatsushi ^a   Ito, Hiroaki ^a   Ogino, Mieko ^a   Kowa, Hisayuki ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Anti GD1b antibodies; Anti GM1 antibodies; Logistic model; Multivariate analysis

Indexed keywords

ANTIBODY; GANGLIOSIDE; GANGLIOSIDE GM1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; POLYRADICULONEUROPATHY;

ADOLESCENT; ADULT; AGED; ANTIBODIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M1) GANGLIOSIDE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY;

EID: 0031228077     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.607     Document Type: Article

References (38)

1. Ilyas AA, Willison HJ, Quarles RH, et al. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 23: 440, 1988.
2. Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 34: 43, 1991.
3. Van den Berg LH, Marrink J, De Jager AEJ, et al. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 55: 8, 1992.
4. Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD. Antibodies to acidic glycolipids in Guillain-Barrev syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 107: 111, 1992.
5. Nobile-Orazio E, Carpo M, Meucci N, et al. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci 109: 200, 1992.
6. Simone IL, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 114: 49, 1993.
7. Yuki N, Yamada M, Sato S, et al. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome. Muscle Nerve 16: 642, 1993.
8. Gregson NA, Koblar S, Hughes RAC. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med 86: 111, 1993.
9. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies. Neurology 43: 1911, 1993.
10. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral nerve myelin. and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neural 34: 130, 1993.
11. Kusunoki S, Chiba A, Kon K, et al. N-Acetylgulactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 35: 570, 1994.
12. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40: 1900, 1990.
13. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 31: 677, 1992.
14. Willison HJ, Veitch J, Paterson G, Kennedy PGF. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 56: 204, 1993.
15. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 (suppl): S21, 1990.
16. Sadiq SA, Thomas FP, Kilidireas K, et al. The spectrum of neurologic-disease associated with anti-GM1 antibodies. Neurology 40: 1067, 1990.
17. Irie S, Saito T, Nakamura K, et al. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. J Neuroimmunol 68: 19, 1996.
18. Freddo L, Yu RK, Latov N, et al. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 36: 454, 1986.
19. Latov N, Hays AP, Donofrio PD, et al. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology 38: 763, 1988.
20. Nardelli B, Steck AJ, Barkas T, Schluep M, Jerusalem F. Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b. Ann Neurol 23: 524, 1988.
21. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24: 73, 1988.
22. Salazar-Grueso FF, Routbort MJ, Martin J, Dawson G, Roos RP. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol 27: 558, 1990.
23. Nobile-Orazio E, Legname G, Daverio R, et al. Motor neuron disease in a patient with a monoclonal IgMk directed against GM1 GD1b, and high-molecular-weight neural-specific glycoproteins. Ann Neurol 28: 190, 1990.
24. Santoro M, Thomas FP, Fink ME, et al. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Ann Neurol 28: 373, 1990.
25. Adams D, Kuntzer T, Burger D, et al. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 32: 223, 1991.
26. Kinsella LJ, Lange LJ, Trojaborg W, Sadiq SA, Younger DS, Latov N. Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers. Neurology 44: 1278, 1994.
27. Corbo M, Quattrini A, Latov N, Hays AP. Localization of GM1 and Gal(β1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 43: 809, 1993.
28. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 38: 809, 1995.
29. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 178: 1771, 1993.
30. Wirguin I, Suturkova-Milosevic LJ, Della-Latta P, Fisher T, Brown RH Jr, Latov N. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann Neurol 35: 698, 1994.
31. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J 288: 1867, 1984.
32. Speed BR, Kaldor J, Watson J, et al. Campylobacter jejuni/Campylobacter coli-associated Guillain-Barré syndrome. Immunoblot confirmation of the serological response. Med J Aust 147: 13, 1987.
33. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RPF. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 51: 613, 1988.
34. Gruenewald R, Ropper AH, Lior H, Chan J, Lee R, Molinaro VS. Serologic evidence Campylobacter jejuni/coli enteritis in patients with Guillain-Barré syndrome. Arch Neurol 48: 1080, 1991.
35. Kuroki S, Saida T, Nukina M, et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-Acetylglucosamine residues. Ann Neurol 33: 243, 1993.
36. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous ;Campylobacter jejuni infection in patients with Guillain-Barré syndrome. Ann Intern Med 118: 947, 1993.
37. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 34: 136, 1993.
38. Vriesendorp FJ, Triggs WJ, Mayer RF, Koski CL. Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1b and Campylobacter jejuni. J Neurol 242: 460, 1995.